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Short Communication
MINOR HISTOCOMPATIBILITY ANTIGENS DO NOT
ENHANCE BALB/c ANTI-SV40 TASA RESPONSE
P. NANNI, C. DE GIOVANNI, M. C. GALLI, S. GRILLI,
P.-L. LOLLINI, G. NICOLETTI AND G. PRODI
From the Centro per lo Studio Sperinientale dei Trapianti e dei Rapporti Tuntore-Ospite, Istituto
di Cancerologia, Universita di Bologna, Bologna, Italy
Received 11 May 1981
THE POSSIBILITY of enhancing the
immune response to a target antigen
when immunizing with both the antigen
itself and a different (adjuvant) antigen is
reported in the literature, in which target
antigen was associated to the surface of
transformed or normal cells. An adjuvant
effect was demonstrated by using syn-
thetic aptens (Martin et al., 1971; Galili
et al., 1976), viral antigens (Boone et al.,
1974), minor histocompatibility antigens
(Di Marco et al., 1972; Lake & Douglas,
1978) and major histocompatibility com-
plex (MHC) antigens as adjuvant antigens.
In particular, positive results have been
obtained with MHC antigens both in rats
(Di Marco et al., 1972) and hamsters
(Streilein & Stein-Streilein, 1978) by skin
graft rejection, and in mice (Colnaghi,
1975) by complement-dependent cyto-
toxicity. In mice, MHC antigens were
unable to play an adjuvant role in cell-
mediated immunity: immunization with
cells bearing target antigen together with
allogeneic MHC did not improve the
response against target antigen on syn-
geneic cells, either in a MHC-matched
system (Mullbacher & Brenan, 1980, immu-
nized with F1 cells bearing both allogeneic
and syngeneic MHC) or in MHC-incom-
patible models (Shearer, 1974; Ting et al.,
1977; Colnaghi et al., 1978). Under these
latter experimental conditions an MHC
restriction (or preference) between immu-
nizing and target cells was shown.
Accepte(t 16 Juie 1981
It is ofinterest, therefore, to investigate
whether an enhancement of the immune
response to tumour-associated surface
antigens (TASA) (SV40-induced TASA in
the present work) occurs in MHC-matched
mice after immunization with TASA along
with minor histocompatibility antigens
(as adjuvant antigens). Response was
evaluated with both an in vitro cell-
mediated cytotoxicity test (3H-proline)
andthe Winn neutralization assay.
The following SV40-tiransformed cell
lines, derived from normal kidney fibro-
blasts, were used:
(a) KB/cSV (BALB/c origin, H-2d) and
KD2SV (BIO.D2 origin, H-2d, differing
from BALB/c at multiple minor histo-
compatibility loci). They both are non-
tumorigenic in immunocompetent animals
(Trinchieri et al., 1976) and were kindly
supplied by Dr G. Trinchieri (Swiss
Institute Cancer Res., Lausanne);
(b) mKSA-Tu5 and mKSA(ASC)
(BALB/c origin). They are both tumori-
genic with a subcutaneous TD50 of 5 x 106
and 102 cells, respectively (Drapkin et al.,
1974) and were kindly supplied by Dr M.
Prat, Institute of Histology, University
ofTrieste, Italy.
Cell-mediated cytotoxicity was evalua-
ted after sensitization by the method of
Trinchieri et al. (1976): 11-12-week-old
BALB/cAnNCr1BR female mice were
immunized i.p., either with 30 x 106
KD2SV cells or with 30 x 106 KB/cSV
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cells in I ml phosphate-buffered saline
(PBS). Control animals received PBS
alone. Eight days later, spleen cells were
collected and used as effectors in the 3H-
proline in vitro cytotoxicity test, which
measures the residual number of pre-
labelled target cells after effector action
(Stutman et al., 1977). Briefly, subcon-
fluent monolayer cultures of target cells
were incubated with 50 kCi/ml of 3H-
proline (L-[3,4(n)-3H]-proline, 41 Ci/mmol
sp. act., The Radiochemical Centre, Amer-
sham) at 37°C in humidified 50 CO2
atmosphere for 24 h in Minimal Essential
Medium supplemented with 10% Foetal
Calf Serum (FCS, GIBCO, Paisley, Scot-
land). 2,000 viable cells/well were seeded
in Microtest II plates (Falcon Plastics,
Oxnard, U.S.A.) in 0-1 ml medium supple-
mented with 1% non-essential amino
acids (Eurobio, Paris, France) (test
medium). Spleen cells were added 6 h
later in 041 ml test medium at 2 effector:
target cell (E:T) ratios (100:1 and 200:1).
After 35-40h incubation, medium was
removed from each well and plates were
washed x 3 by soaking into PBS (made
5%o FCS) at 37°C, emptied and left to
dry. Then plates were sprayed with a
protective lacquer (Condor, Milan, Italy)
and the bottoms ofthe wells were punched
out with a hand-operated cam punch press
(kindly manufactured by Mr 0. Schiassi,
Inst. Gen. Pathology, Bologna) and
transferred to scintillation vials. Luma-
solve 041 ml (Lumac, Basle, Switzerland)
was added to each vial at room tempera-
ture and, after a 30-min solubilization
period, 5 ml scintillation liquid (0-4%O
PPO and 0-0050o POPOP in toluene)
were added. Vials were kept at 4°C in the
dark for at least 24 h before counting in
an Intertechnique SL 32 (Plaisir, France)
liquid scintillation spectrometer provided
with 226Ra external standard (efficiency
400 o).
Each variable was tested in sextuplicate.
The results are expressed as percent
cytotoxicity calculated by the formula
100(1-A/B) in which A=target cell
d/min remaining after incubation with
sensitized spleen cells, and B =target cell
d/min remaining after incubation with
unsensitized spleen cells. Spontaneous
cytotoxicity was calculated as 100(1-
B/C) in which C =target cell d/min re-
maining after incubation in the absence of
spleen cells. Target cells used as specificity
control in the cytotoxic anti-SV40 TASA
response were the following: BALB/3T3
(normal fibroblasts) and M-MSV-BALB/
3T3 (non-producer MMSV-transformed
BALB/c 3T3), obtained from The Ameri-
can Type Culture Collection, Rockville,
Md, U.S.A.
The Winn neutralization assay was
performed by the method described by
Glaser & Lotan (1979): 9-10-week-old
BALB/c females were immunized s.c.
with 106 KD2SV, KB/cSV or mKSA-Tu5
cells. Twenty days later, spleen cells
from 2-3 animals were pooled, mixed with
105 freshly harvested mKSA(ASC) cells
at different ratios (25:1, 50:1, 100:1),
suspended in 0-2 ml PBS and injected
s.c. (left hind leg) into 11-12-week-old
BALB/c females (9-10 animals per group).
Statistical evaluation was performed by
t and factorial x2 tests.
The results from the in vitro cytotoxicity
test are shown in Fig. 1. The immuniza-
tion with KD2SV cells did not induce a
cytotoxic response against syngeneic
SV40-transformed cells higher than that
after immunization with syngeneic cells;
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FIG. 2.-Tumour-free female BALB/c mice
(%) in the Winn neutralization assay. Each
animal received a single s.c. injection of
105 mKSA(ASC) cells mixed with spleen
cells from BALB/c females immunized with
KB/cSV (Z1), KD2SV (U) or mKSA-Tu5
(.) cells, or unimmunized (*). In the
combination KB/cSV, 25:1, it was possible
to evaluate only 7 of the 9-10 animals
usually used in the other groups. Evaluation
was performed after the death of all
tumour-bearing animals, i.e. 4 months after
mKSA(ASC) treatment.
either way there was little cytotoxicity.
We also immunized female mice with cells
subjected to y-irradiation (50 Gy); again
no adjuvant effect was found. The same
result was found when male BALB/c
mice were immunized with the same cell
lines.
Neither the Winn neutralization assay
(Fig. 2) nor the in vitro cytotoxicity test
detected an adjuvant effect by minor
histocompatibility antigens. Strong pro-
tection is observed (Winn assay) by syn-
geneically immunized spleen cells, even
though mKSA-Tu5 cells are less (though
not significantly) effective than KB/cSV
cells. The protection induced by KD2SV
cells is never greater than that due to
either of the 2 syngeneic lines, being
statistically similar to that with mKSA-
Tu5 and lower than that with KB/cSV.
Using an in vitro cytotoxicity test
involving cell prelabelling with 3H-proline,
we found a low response against syngeneic
SV40-transformed cells in a H-2d haplo-
type strain, comparedtothehigheramount
found in a H-2b strain (Table). In fact,
C57BL/6 mice immunized with a syn-
geneic SV40-transformed cell line (C57SV,
TABLE.-Anti-SV40 TASA response in
BALB/c and C57BL/6 mice evaluated
by the 3H-proline cytotoxicity test (mean
+s.e.)
% cytotoxicity
Immun- at E: T
izing Target
Effector cell cell 100:1 200:1
BALB/c (5)* KB/cSV KB/cSV 14+4 24+8
C57BL/6 (4) C57SV C57SV 68 + 4 73 +1
* No. ofexperiments.
from Dr G. Trinchieri) showed strong
cytotoxicity against the immunizing cells.
The same phenomenon was detected by
Knowles et al. (1979), who used a different
assay (51Cr release).
The low-responding BALB/c system
could be a suitable model for detecting
enhancement of in vitro cytotoxicity.
Nevertheless, the results of in vitro cyto-
toxicity do not support the hypothesis of
an adjuvant effect by minor histocompati-
bility antigens on the response to SV40-
induced TASA, and are further confirmed
by the Winn test results. We wish to
underline that, with the latter technique,
the spleen cells sensitized against syn-
geneic cells are able to neutralize almost
completely the growth of a syngeneic
H-2d tumour.
In conclusion, both the 3H-proline in
vitro cytotoxicity test and the Winn neu-
tralization assay failed to detect an en-
hancement ofthe immune response against
SV40-transformed syngeneic cells in
BALB/c mice immunized with H-2
matched SV40-transformed cells differing
at multiple minor histocompatibility loci.
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